Skip to main
ELMD
ELMD logo

Electromed (ELMD) Stock Forecast & Price Target

Electromed (ELMD) Analyst Ratings

Based on 3 analyst ratings
Strong Buy
Strong Buy 100%
Buy 0%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

Electromed Inc. reported a significant 14.8% growth in homecare revenue, reaching $14.1 million, driven by improved sales rep productivity, streamlined reimbursement processes, and effective demand generation strategies. The company has established a robust presence in the domestic homecare market while also expanding into acute care and select international regions, enhancing its growth potential. Additionally, the 17.2% rise in selling, general and administrative (SG&A) expenses, attributed to increased headcount in key areas, underscores Electromed's commitment to investing in growth and supporting its expanding operations.

Bears say

Electromed Inc faces a negative outlook primarily due to margin compression, competitive headwinds, and reduced sales rep productivity, which are significant concerns affecting its financial performance. The company has experienced a notable decline in its stock price, dropping from a recent high of $35.43 to approximately $18, highlighting a troubling downward trend. These factors, combined with the competitive landscape, suggest challenges for Electromed in maintaining sales momentum and profitability going forward.

Electromed (ELMD) has been analyzed by 3 analysts, with a consensus rating of Strong Buy. 100% of analysts recommend a Strong Buy, 0% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Electromed and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Electromed (ELMD) Forecast

Analysts have given Electromed (ELMD) a Strong Buy based on their latest research and market trends.

According to 3 analysts, Electromed (ELMD) has a Strong Buy consensus rating as of Oct 14, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $36.33, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $36.33, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Electromed (ELMD)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.